Entrada Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $887k | 51k | 17.27 |
| 2024-09-30 | $720k | 45k | 15.96 |
| 2024-06-30 | $208k | 15k | 14.32 |
| 2024-03-31 | $318k | 23k | 14.12 |
| 2023-12-31 | $479k | 32k | 15.10 |
| 2023-09-30 | $94k | 5.9k | 15.85 |
| 2023-06-30 | $97k | 6.4k | 15.10 |
| 2023-03-31 | $149k | 10k | 14.55 |
| 2022-12-31 | $146k | 11k | 13.55 |
| 2022-09-30 | $19k | 1.2k | 15.64 |
| 2022-06-30 | $0 | 36 | 0.00 |
| 2022-03-31 | $16k | 1.7k | 9.36 |